220 related articles for article (PubMed ID: 22330914)
1. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
Malcolm RK; Veazey RS; Geer L; Lowry D; Fetherston SM; Murphy DJ; Boyd P; Major I; Shattock RJ; Klasse PJ; Doyle LA; Rasmussen KK; Goldman L; Ketas TJ; Moore JP
Antimicrob Agents Chemother; 2012 May; 56(5):2251-8. PubMed ID: 22330914
[TBL] [Abstract][Full Text] [Related]
2. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
Veazey RS; Ketas TJ; Dufour J; Moroney-Rasmussen T; Green LC; Klasse PJ; Moore JP
J Infect Dis; 2010 Sep; 202(5):739-44. PubMed ID: 20629537
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application.
Malcolm RK; Lowry D; Boyd P; Geer L; Veazey RS; Goldman L; Klasse PJ; Shattock RJ; Moore JP
J Antimicrob Chemother; 2014 May; 69(5):1325-9. PubMed ID: 24381072
[TBL] [Abstract][Full Text] [Related]
4. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques.
Malcolm RK; Forbes CJ; Geer L; Veazey RS; Goldman L; Klasse PJ; Moore JP
J Antimicrob Chemother; 2013 Mar; 68(3):678-83. PubMed ID: 23111849
[TBL] [Abstract][Full Text] [Related]
6. Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.
Barouch DH; Klasse PJ; Dufour J; Veazey RS; Moore JP
Proc Natl Acad Sci U S A; 2012 May; 109(22):8694-8. PubMed ID: 22586094
[TBL] [Abstract][Full Text] [Related]
7. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
[TBL] [Abstract][Full Text] [Related]
8. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
Veazey RS; Springer MS; Marx PA; Dufour J; Klasse PJ; Moore JP
Nat Med; 2005 Dec; 11(12):1293-4. PubMed ID: 16273102
[TBL] [Abstract][Full Text] [Related]
9. Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.
Brocca-Cofano E; Xu C; Wetzel KS; Cottrell ML; Policicchio BB; Raehtz KD; Ma D; Dunsmore T; Haret-Richter GS; Musaitif K; Keele BF; Kashuba AD; Collman RG; Pandrea I; Apetrei C
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925666
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.
Nuttall J; Kashuba A; Wang R; White N; Allen P; Roberts J; Romano J
Antimicrob Agents Chemother; 2012 Jan; 56(1):103-9. PubMed ID: 21986823
[TBL] [Abstract][Full Text] [Related]
11. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
Dobard CW; Taylor A; Sharma S; Anderson PL; Bushman LR; Chuong D; Pau CP; Hanson D; Wang L; Garcia-Lerma JG; McGowan I; Rohan L; Heneine W
J Infect Dis; 2015 Dec; 212(12):1988-95. PubMed ID: 26071566
[TBL] [Abstract][Full Text] [Related]
12. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.
Dobard C; Sharma S; Martin A; Pau CP; Holder A; Kuklenyik Z; Lipscomb J; Hanson DL; Smith J; Novembre FJ; García-Lerma JG; Heneine W
J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766
[TBL] [Abstract][Full Text] [Related]
13. Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.
Moss JA; Butkyavichene I; Churchman SA; Gunawardana M; Fanter R; Miller CS; Yang F; Easley JT; Marzinke MA; Hendrix CW; Smith TJ; Baum MM
Antimicrob Agents Chemother; 2016 Jun; 60(6):3759-66. PubMed ID: 27067321
[TBL] [Abstract][Full Text] [Related]
14. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.
Neff CP; Kurisu T; Ndolo T; Fox K; Akkina R
PLoS One; 2011; 6(6):e20209. PubMed ID: 21673796
[TBL] [Abstract][Full Text] [Related]
15. C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.
Veazey RS; Chatterji U; Bobardt M; Russell-Lodrigue KE; Li J; Wang X; Gallay PA
Antimicrob Agents Chemother; 2016 Jan; 60(1):693-8. PubMed ID: 26552985
[TBL] [Abstract][Full Text] [Related]
16. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
[TBL] [Abstract][Full Text] [Related]
17. Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220.
Fetherston SM; Geer L; Veazey RS; Goldman L; Murphy DJ; Ketas TJ; Klasse PJ; Blois S; La Colla P; Moore JP; Malcolm RK
J Antimicrob Chemother; 2013 Feb; 68(2):394-403. PubMed ID: 23109186
[TBL] [Abstract][Full Text] [Related]
18. Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues.
Massud I; Aung W; Martin A; Bachman S; Mitchell J; Aubert R; Solomon Tsegaye T; Kersh E; Pau CP; Heneine W; García-Lerma JG
J Virol; 2013 Aug; 87(16):8952-61. PubMed ID: 23740994
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
20. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.
Andrews CD; Yueh YL; Spreen WR; St Bernard L; Boente-Carrera M; Rodriguez K; Gettie A; Russell-Lodrigue K; Blanchard J; Ford S; Mohri H; Cheng-Mayer C; Hong Z; Ho DD; Markowitz M
Sci Transl Med; 2015 Jan; 7(270):270ra4. PubMed ID: 25589630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
